Actively Recruiting
Special Drug Use-results Surveillance of Tafinlar/Mekinist
Led by Novartis Pharmaceuticals · Updated on 2025-12-30
110
Participants Needed
68
Research Sites
411 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, multicenter, single-arm, non-interventional and observational J-PMS conducted by the central registration system and operated in Electronic data capture.
CONDITIONS
Official Title
Special Drug Use-results Surveillance of Tafinlar/Mekinist
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have given written consent to cooperate in this surveillance
- For patients under 18 years at treatment start, their legally authorized representative must have given written informed consent
- Patients starting treatment with the product for BRAF mutation-positive advanced or recurrent solid tumors (excluding colorectal cancer) after approval of additional indications
You will not qualify if you...
- Patients who have received or are receiving the same drug in any other study or research besides this surveillance
- Patients with BRAF mutation-positive malignant melanoma
- Patients with BRAF mutation-positive non-small cell lung cancer
- Patients with BRAF mutation-positive hairy cell leukemia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 68 locations
1
Novartis Investigative Site
Nagakute, Aichi-ken, Japan, 480-1195
Completed
2
Novartis Investigative Site
Nagoya, Aichi-ken, Japan, 453-8511
Actively Recruiting
3
Novartis Investigative Site
Nagoya, Aichi-ken, Japan, 453-8511
Completed
4
Novartis Investigative Site
Nagoya, Aichi-ken, Japan, 464 8681
Completed
5
Novartis Investigative Site
Toyohashi, Aichi-ken, Japan, 441-8570
Completed
6
Novartis Investigative Site
Toyota, Aichi-ken, Japan, 470-0343
Completed
7
Novartis Investigative Site
Daisen, Akita, Japan, 014-0027
Completed
8
Novartis Investigative Site
Chiba, Chiba, Japan, 260 8677
Actively Recruiting
9
Novartis Investigative Site
Funabashi, Chiba, Japan, 273-8588
Completed
10
Novartis Investigative Site
Kashiwa, Chiba, Japan, 277 8577
Actively Recruiting
11
Novartis Investigative Site
Fukuoka, Fukuoka, Japan, 811-1395
Actively Recruiting
12
Novartis Investigative Site
Kurume, Fukuoka, Japan, 830-0011
Actively Recruiting
13
Novartis Investigative Site
Fukuyama, Hiroshima, Japan, 721-8511
Actively Recruiting
14
Novartis Investigative Site
Sapporo, Hokkaido, Japan, 065-0033
Actively Recruiting
15
Novartis Investigative Site
Sapporo, Hokkaido, Japan, 608543
Actively Recruiting
16
Novartis Investigative Site
Amagasaki, Hyōgo, Japan, 660-8511
Completed
17
Novartis Investigative Site
Kobe, Hyōgo, Japan, 650-0011
Completed
18
Novartis Investigative Site
Kobe, Hyōgo, Japan, 6500047
Actively Recruiting
19
Novartis Investigative Site
Mito, Ibaraki, Japan, 311-4145
Actively Recruiting
20
Novartis Investigative Site
Morioka, Iwate, Japan, 020 0066
Completed
21
Novartis Investigative Site
Kagoshima, Kagoshima-ken, Japan, 890 8520
Actively Recruiting
22
Novartis Investigative Site
Sagamihara, Kanagawa, Japan, 252-0375
Actively Recruiting
23
Novartis Investigative Site
Yokohama, Kanagawa, Japan, 245-8575
Actively Recruiting
24
Novartis Investigative Site
Yokohama, Kanagawa-ku, Japan, 236-0004
Actively Recruiting
25
Novartis Investigative Site
Kyoto, Kyoto, Japan, 602-8566
Actively Recruiting
26
Novartis Investigative Site
Natori-shi, Miyagi, Japan, 981-1293
Completed
27
Novartis Investigative Site
Sendai, Miyagi, Japan, 980 8574
Actively Recruiting
28
Novartis Investigative Site
Iida, Nagano, Japan, 395-8502
Active, Not Recruiting
29
Novartis Investigative Site
Matsumoto, Nagano, Japan, 3908621
Actively Recruiting
30
Novartis Investigative Site
Matsumoto, Nagano, Japan, 3908621
Completed
31
Novartis Investigative Site
Yufu, Oita Prefecture, Japan, 8795593
Actively Recruiting
32
Novartis Investigative Site
Okayama, Okayama-ken, Japan, 7011192
Actively Recruiting
33
Novartis Investigative Site
Habikino, Osaka, Japan, 583-0872
Actively Recruiting
34
Novartis Investigative Site
Izumisano, Osaka, Japan, 5988577
Completed
35
Novartis Investigative Site
Osaka, Osaka, Japan, 5340021
Actively Recruiting
36
Novartis Investigative Site
Osaka, Osaka, Japan, 5340021
Completed
37
Novartis Investigative Site
Osaka, Osaka, Japan, 550-0015
Completed
38
Novartis Investigative Site
Takatsuki, Osaka, Japan, 5698686
Actively Recruiting
39
Novartis Investigative Site
Kawagoe, Saitama, Japan, 350 8550
Actively Recruiting
40
Novartis Investigative Site
Saitama, Saitama, Japan, 330 8777
Actively Recruiting
41
Novartis Investigative Site
Sunto Gun, Shizuoka, Japan, 411 8777
Actively Recruiting
42
Novartis Investigative Site
Shimotsuke, Tochigi, Japan, 329-0498
Completed
43
Novartis Investigative Site
Bunkyo Ku, Tokyo, Japan, 113 8655
Actively Recruiting
44
Novartis Investigative Site
Bunkyo Ku, Tokyo, Japan, 113 8655
Completed
45
Novartis Investigative Site
Bunkyo-ku, Tokyo, Japan, 113-8603
Completed
46
Novartis Investigative Site
Bunkyo-ku, Tokyo, Japan, 1138519
Actively Recruiting
47
Novartis Investigative Site
Bunkyo-ku, Tokyo, Japan, 1138519
Completed
48
Novartis Investigative Site
Chuo Ku, Tokyo, Japan, 104 0045
Completed
49
Novartis Investigative Site
Chuo Ku, Tokyo, Japan, 104 0045
Actively Recruiting
50
Novartis Investigative Site
Chuo Ku, Tokyo, Japan, 104 8560
Actively Recruiting
51
Novartis Investigative Site
Minato-ku, Tokyo, Japan, 105-8471
Actively Recruiting
52
Novartis Investigative Site
Minato-ku, Tokyo, Japan, 108-8639
Completed
53
Novartis Investigative Site
Setagaya-ku, Tokyo, Japan, 1578535
Actively Recruiting
54
Novartis Investigative Site
Shibuya City, Tokyo, Japan, 150-8308
Completed
55
Novartis Investigative Site
Shinjuku Ku, Tokyo, Japan, 160-0023
Completed
56
Novartis Investigative Site
Shinjuku Ku, Tokyo, Japan, 162 8666
Completed
57
Novartis Investigative Site
Shinjuku-ku, Tokyo, Japan, 160 8582
Actively Recruiting
58
Novartis Investigative Site
Wakayama, Wakayama, Japan, 641-8510
Completed
59
Novartis Investigative Site
Wakayama, Wakayama, Japan, 641-8510
Actively Recruiting
60
Novartis Investigative Site
Yamagata, Yamagata, Japan, 990 9585
Active, Not Recruiting
61
Novartis Investigative Site
Akita, Japan, 010-8543
Active, Not Recruiting
62
Novartis Investigative Site
Fukuoka, Japan, 8128582
Actively Recruiting
63
Novartis Investigative Site
Hiroshima, Japan, 7348551
Actively Recruiting
64
Novartis Investigative Site
Kochi, Japan, 781 8555
Actively Recruiting
65
Novartis Investigative Site
Kyoto, Japan, 606 8507
Actively Recruiting
66
Novartis Investigative Site
Okayama, Japan, 7008558
Actively Recruiting
67
Novartis Investigative Site
Osaka, Japan, 5458586
Completed
68
Novartis Investigative Site
Shizuoka, Japan, 420 8660
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here